XML 37 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:      
Net profit (loss) $ (2,201) $ (1,540) $ 112
Adjustments to reconcile net profit (loss) to net cash from (used in) operating activities:      
Share-based compensation 60
Depreciation and amortization of intangible assets 570 524 104
Impairment of intangible asset 87
Accrued interest and amortization of discount on third party loans (Note 8) 95 222
Gain from debt extinguishment (14)
Change in fair value of derivative liabilities (2,822) 75
Accrued interest and amortization of discount on related party and shareholders’ loans (Note 8) 203 324 162
Interest expense on short-term loan (25)
Benefit for deferred taxes (15) (115) (50)
Operating lease right-of-use assets 14
Issuance costs on derivative liabilities 1,416
Changes in operating assets and liabilities:      
Decrease (increase) in trade receivables 39 (282) 43
Decrease (increase) related party balance 40 (40)
Decrease (increase) in other receivables (743) (290) 96
Decrease (increase) in inventory (564) (449) (638)
Increase (decrease) related party liabilities (213) 241 14
Increase (decrease) accounts payable and other payables (579) 254 323
Decrease in operating lease liabilities (15)
Net cash from (used in) operating activities (4,840) (863) 126
CASH FLOWS USED IN INVESTING ACTIVITIES:      
Purchase of property and equipment (41) (2) (1)
Purchase of intangible assets (4,728) (100)
Net cash used in investing activities (41) (4,730) (101)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Short-term loan received 752 981
Short-term loan repaid (1,518) (134) (196)
Proceeds from initial public offering, net of issuance costs 13,391
Loan received from shareholders 4,800 250
Loan repaid to shareholders (100)
Loan received (repaid) from related parties (1,102) 105
Issuance of ordinary shares 1,250 [1]
Net cash from financing activities 12,625 5,695 159
NET INCREASE IN CASH AND CASH EQUIVALENTS 7,744 102 184
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR 393 291 107
CASH AND CASH EQUIVALENTS AT END OF THE YEAR 8,137 393 291
Supplemental disclosure of cash flow information:      
Taxes paid 73 116 3
Interest paid 477 4
Supplemental disclosure of noncash investing and financing activities:      
Deferred offering costs included in other payables 86
Share-based compensation included in deferred offering costs 75
Issuance of ordinary shares upon conversion of shareholders’ loans 2,839    
Substantial modification of shareholders’ loans recorded in equity 982    
Right of use assets obtained in exchange for lease liabilities $ 152
[1] Amount less than $1 thousand